Notable from Our Podcast
The featured interview from the January 29th podcast highlights brain death, the determination of brain death, and member guidance for brain death accommodation requests. In the What's Trending segment, you'll hear a discussion on tau protein and Alzheimer dementia symptoms.
Author Tip
Neurology® has recently adopted the following policy in support of the movement to promote data transparency: Data not provided in a neurology article because of space limitations must be made available in a trusted data repository or shared at the request of other investigators for purposes of replicating procedures and results. Neurology has created a mechanism for editors and peer reviewers to review data deposited in the Dryad public repository at the time of manuscript submission. Authors will pay a nominal fee for depositing data in a public repository (waivers exist for submissions from authors based in countries classified by the World Bank as low- or middle-income economies).
From the AAN Press Room
Visit AAN.com/pressroom for the latest press releases
Certain antidepressants linked to a slightly smaller risk of stroke
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. Now a new study has found certain SSRIs and other antidepressants that increase serotonin levels in the brain the most may be associated with a reduced risk of ischemic stroke when compared to antidepressants that increase serotonin levels the least. “It is not uncommon for people with depression to also have heart disease, a risk factor for stroke, so it is important to investigate whether antidepressants raise or lower the risk of stroke,” said study author Christel Renoux, MD, PhD, of McGill University in Montreal, Canada. “While studies investigating stroke risk in people who take antidepressants compared to people who do not take them have found mixed results, our study took an even closer look, investigating stroke risk in people who take antidepressants that increase serotonin levels the most compared to people who take antidepressants that increase levels the least.”
Douros A, Dell'Aniello S, Dehghan G, Boivin JF, Renoux C. Neurology 2019;93:e1010–e1020. doi.org/10.1212/WNL.0000000000008060
CME
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
Page 660
Postictal serotonin levels are associated with peri-ictal apnea
Page 664
Most-Read Articles
As of February 22, 2019
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
G. McKhann, D. Drachman, M. Folstein, et al. 1984;34:939–944. doi.org/10.1212/WNL.34.7.939
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
J.F. Kurtzke. 1983;33:1444–1452. doi.org/10.1212/WNL.33.11.1444
Parkinsonism: onset, progression, and mortality
M.M. Hoehn, M.D. Yahr. 1967;17:427–442. doi.org/10.1212/WNL.17.5.427
Neurosurgical horizons in Parkinson's disease
C.G. Goetz, M.R. De Long, R.D. Penn, R.A.E. Bakay. 1993;43:1–7. doi.org/10.1212/WNL.43.1_Part_1.1
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue
R.N. Rosenberg. 1995;45:1–5. doi.org/10.1212/WNL.45.1.1
- Received August 9, 2019.
- Accepted in final form August 9, 2019.
- © 2019 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Degree of serotonin reuptake inhibition of antidepressants and ischemic risk
Practice Current: When do you order ancillary tests to determine brain death?
An interdisciplinary response to contemporary concerns about brain death determination
SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage